What Is Orlistat?
Orlistat is a lipase inhibitor that works in the digestive tract to reduce the absorption of approximately 25–30% of dietary fat from meals. Unlike stimulant medications, orlistat does not act on the central nervous system.
Orlistat is FDA-approved in two formulations:
- Xenical® (120 mg), available by prescription
- Alli® (60 mg), available over the counter
Some compounded MedKits available through the Eden platform may include low-dose orlistat. Licensed healthcare providers may prescribe these formulations as part of a personalized approach to support long-term metabolic health and lifestyle consistency.
Phentermine vs Orlistat: A Side-by-Side Overview of FDA-Approved Options
Feature |
Orlistat (Generic for Xenical® / Alli®) |
Phentermine (Generic, e.g., Adipex-P®) |
FDA-approved for weight loss |
Yes |
Yes |
Type |
Gastrointestinal Lipase inhibitor |
Central Nervous System Stimulant |
Primary mechanism |
Inhibits fat absorption in the gut |
Suppresses appetite via CNS stimulation |
Risk of dependence |
No |
Potential, due to stimulant classification (Schedule IV) |
GI side effects |
Common (oily stools, flatulence) |
Rare |
Cardiovascular considerations |
Generally low |
May increase heart rate and blood pressure |
Duration of use |
Approved for long-term use (e.g., Xenical®) |
Approved for short-term use only (few weeks) |
May be included in compounded MedKits from Eden platform |
Yes, in compounded form as prescribed by licensed healthcare providers |
No |
The inclusion of any compounded medication in a MedKit depends on an individual evaluation and prescription by a licensed healthcare provider. Orlistat used in compounded form is not identical to over-the-counter or branded prescription versions.
Why Licensed Healthcare Providers on the Eden Platform May Recommend Orlistat Over Phentermine
Licensed healthcare providers on the Eden platform emphasize sustainable strategies that support metabolic health without relying on stimulant medications. While phentermine may be effective for short-term appetite suppression, it may not align with long-term approaches due to:
- Its classification as a Schedule IV controlled substance, indicating potential for dependence
- Known cardiovascular effects, including elevated heart rate and blood pressure
- FDA indication limited to short-term use (typically a few weeks)
Instead, some compounded MedKits available through the Eden platform may include low-dose orlistat, often alongside other ingredients such as:
- Inositol
- Acetyl-L-carnitine
- Vitamins B6 and B12
- Low-dose naltrexone
Licensed healthcare providers may prescribe these to support metabolic consistency, energy balance, or lifestyle adherence, without the use of stimulant-based medications. These compounded formulations are not FDA-approved as fixed combinations. They are prescribed based on clinical judgment and individualized assessments by licensed healthcare providers. Results vary.
When Each Medication May Be Considered
Phentermine may be considered in certain short-term settings under the supervision of a licensed healthcare provider, particularly when:
- A patient presents with high-risk obesity and the provider determines short-term appetite suppression may be beneficial
- The individual has no history of stimulant sensitivity or cardiovascular contraindications
- A short-term intervention is clinically appropriate and consistent with the FDA-approved use of phentermine
Licensed healthcare providers may consider orlistat-based strategies when:
- Long-term support for weight management and fat absorption modulation is appropriate
- A non-stimulant approach is preferred based on individual tolerance or medical history
- A patient experiences challenges with meal timing, dietary patterns, or overconsumption of high-fat meals
- There is sensitivity to stimulants, certain antidepressants (e.g., SSRIs), or medications that affect sleep
Licensed healthcare providers on the Eden platform evaluate an individual’s medical history, treatment goals, and tolerance before prescribing any compounded formulations or recommending a care plan.
Disclaimer
Phentermine and orlistat are both FDA-approved medications for weight management under specific conditions. Phentermine is approved for short-term use, while orlistat is approved for long-term use in conjunction with diet and exercise.
Licensed healthcare providers on the Eden platform do not prescribe phentermine, due to its stimulant profile, controlled substance classification, and limited duration of use. Some compounded MedKits available through the platform may include orlistat in customized, lower-dose formulations when medically appropriate.
These compounded formulations are prepared by state-licensed compounding pharmacies and are not identical to FDA-approved commercial products. Eden does not manufacture, dispense, or prescribe medications. All prescribing decisions are made independently by licensed healthcare providers. Individual results may vary.
Interested in a personalized, non-stimulant approach to metabolic health? Connect with a licensed healthcare provider on the Eden platform to explore your options.
{{primary-cta}}